高级检索
当前位置: 首页 > 详情页

A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Akeso [2]Cancer hospital, Chinese academy of medical sciences and Peking union medical college [3]Henan Cancer Hospital [4]The first affiliated hospital of bengbu medical college,Bengbu,Anhui,China,233099 [5]Anhui provincial hospital,Hefei,Anhui,China,230001 [6]Anhui provincial cancer hospital,Hefei,Anhui,China,230088 [7]The first affiliated hospital of wannan medical college,Wuhu,Anhui,China,241001 [8]Cancer hospital, Chinese academy of medical sciences and Peking union medical college,Beijing,Beijing,China,100021 [9]The Fifth Medical Center of the Chinese People's Liberation Army General Hospital,Beijing,Beijing,China,100039 [10]Beijing Cancer Hospital,Beijing,Beijing,China,100142 [11]Beijing Chest hospital,Beijing,Beijing,China,101149 [12]Chongqing University Cancer Hospital,Chongqing,Chongqing,China,400030 [13]Fujian cancer hospital,Fuzhou,Fujian,China,350014 [14]Zhangzhou municipal hospital of fujian province,Zhangzhou,Fujian,China,363099 [15]Gansu provincial cancer hospital,Lanzhou,Gansu,China,730050 [16]The First Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China,510080 [17]Affiliated cancer hospital and institute of guangzhou medical university,Guangzhou,Guangdong,China,510095 [18]Nanfang hospital,Guangzhou,Guangdong,China,510515 [19]Cancer hospital Chinses academy of medical sciences, shenzhen center,Shenzhen,Guangdong,China,518172 [20]Hainan cancer hospital,Haikou,Hainan,China,570312 [21]Affiliated hospital of Hebei university,Baoding,Hebei,China,050031 [22]The second people's hospital of Hengshui,Hengshui,Hebei,China,053099 [23]The Second Hospital of HeBei Medical University,Shijiazhuang,Hebei,China,050004 [24]The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China,050011 [25]Tangshang people's hospital,Tangshan,Hebei,China,063001 [26]Harbin medical university cancer hospital,Harbin,Heilongjiang,China,150081 [27]Jiamusi Tuberculosis Prevention and Control Hospital (Jiamusi Cancer Hospital),Jiamusi,Heilongjiang,China,154007 [28]The first hospital of Qiqihar,Qiqihar,Heilongjiang,China,161005 [29]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China,450052 [30]Nanyang central hospital,Nanyang,Henan,China,473005 [31]The First Affiliated Hospital of Xinxiang Medical College,Xinxiang,Henan,China,45310 [32]Henan Cancer Hospital,Zhengzhou,Henan,China,450003 [33]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450052 [34]Renmin Hospital of Wuhan University,Wuhan,Hubei,China,430060 [35]Hubei Cancer Hospital,Wuhan,Hubei,China,430079 [36]Xiangya Hospital of Central South University,Changsha,Hunan,China,410008 [37]The Second Xiangya Hospital, Central South University,Changsha,Hunan,China,410012 [38]Hunan Cancer Hospital,Changsha,Hunan,China,410013 [39]The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China,215006 [40]The affiliated hospital of xuzhou medical university,Xuzhou,Jiangsu,China,221799 [41]First Affiliated Hospital of Gannan medical college,Ganzhou,Jiangxi,China,341000 [42]First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006 [43]The first hospital of Jilin Universit,Changchun,Jilin,China,130061 [44]Tonghua Central Hospital,Tonghua,Jilin,China,134099 [45]The First Hospital of China medical University,Shenyang,Liaoning,China,110002 [46]Liaoning cancer hospital,Shenyang,Liaoning,China,110801 [47]General hospital of ningxia medical university,Yinchuan,Ningxia,China,750003 [48]Qinghai university affiliated hospital,Xining,Qinghai,China,810012 [49]Binzhou medical university hospital,Binzhou,Shandong,China,256603 [50]Shandong Cancer Hospital,Jinan,Shandong,China,250117 [51]The Affiliated Hospital of Qingdao University,Qingdao,Shandong,China,266000 [52]Weifang NO.2 people's Hospital,Weifang,Shandong,China,261041 [53]Zhongshan Hospital, Fudan university,Shanghai,Shanghai,China,200032 [54]Changzhi people's hospital,Changzhi,Shanxi,China,046099 [55]Shanxi Cancer hospital,Taiyuan,Shanxi,China,030013 [56]The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shanxi,China,710061 [57]Sichuan Cancer Hospital,Chengdu,Sichuan,China,610042 [58]Mianyang central hospital,Mianyang,Sichuan,China,621099 [59]The Second People's Hospital of Yibin City,Yibin,Sichuan,China,644000 [60]Tianjin Medical University Cancer Institute & Hospital,Tianjin,Tianjin,China,300060 [61]Tianjin Chest Hospital,Tianjin,Tianjin,China,300222 [62]Xinjiang Medical University Cancer Hospital,Urumqi,Xinjiang,China,830000 [63]Yunnan Cancer Hospital /the Third Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China,650118 [64]The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU),Hangzhou,Zhejiang,China,310003 [65]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310005

研究目的:
This is a randomized, double-blind, phase III clinical study to compare the efficacy and safety of AK104 combined chemotherapy versus Tislelizumab combined chemotherapy in first-line treatment of Locally advanced or metastatic NSCLC with PD-L1 TPS < 1%.

资源点击量:56484 今日访问量:0 总访问量:4732 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号